OK Biotech Co., Ltd. (TPE:4155)

OK Biotech Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 17, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,294	3,007	3,656	2,643	2,217	2,524
Market Cap Growth	-24.00%	-17.75%	38.36%	19.21%	-12.17%	2.03%
Enterprise Value	2,902	3,384	3,420	2,738	2,319	2,476
Last Close Price	16.15	20.08	24.35	20.37	16.52	18.04
PE Ratio	28.36	32.00	1240.26	18.42	51.00	19.45
PS Ratio	1.33	1.80	3.07	1.78	1.76	1.70
PB Ratio	0.90	1.17	1.53	1.43	1.30	1.45
P/TBV Ratio	1.14	1.49	1.54	1.46	1.34	1.51
P/FCF Ratio	-	-	-	-	-	37.16
P/OCF Ratio	18.14	45.63	1246.60	10.99	101.24	17.03
EV/Sales Ratio	1.68	2.03	2.87	1.85	1.84	1.67
EV/EBITDA Ratio	20.23	27.02	56.71	16.50	38.83	14.46
EV/EBIT Ratio	42.63	59.15	-	26.89	286.69	19.63
EV/FCF Ratio	-8.60	-	-	-	-	36.46
Debt / Equity Ratio	0.33	0.28	0.14	0.42	0.43	0.18
Debt / EBITDA Ratio	6.01	5.57	5.23	4.60	11.49	1.79
Debt / FCF Ratio	-	-	-	-	-	4.63
Asset Turnover	0.50	0.49	0.39	0.51	0.47	0.63
Inventory Turnover	2.99	3.02	2.44	2.85	2.97	3.24
Quick Ratio	1.15	1.18	1.48	1.26	1.50	1.34
Current Ratio	1.91	1.98	2.28	1.84	2.13	1.95
Return on Equity (ROE)	3.84%	4.29%	-0.07%	7.70%	1.83%	7.98%
Return on Assets (ROA)	1.19%	1.06%	-0.25%	2.17%	0.19%	3.32%
Return on Capital (ROIC)	1.35%	1.19%	-0.28%	2.51%	0.22%	4.04%
Return on Capital Employed (ROCE)	2.20%	1.90%	-	4.60%	0.40%	6.70%
Earnings Yield	3.60%	3.13%	0.08%	5.43%	1.96%	5.14%
FCF Yield	-14.70%	-10.33%	-11.67%	-1.75%	-2.58%	2.69%
Dividend Yield	1.86%	1.49%	1.23%	5.48%	5.49%	7.04%
Payout Ratio	53.37%	46.95%	4906.38%	66.17%	303.37%	86.44%
Buyback Yield / Dilution	-6.77%	-14.02%	1.41%	-9.95%	-18.84%	-16.16%
Total Shareholder Return	-4.93%	-12.53%	2.64%	-4.47%	-13.35%	-9.12%

Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.